Celiac Disease Foundation is proud to have been a funder and to participate on the Steering Committee for the FDA Gastroenterology Regulatory Endpoints and Advancement of Therapeutics (GREAT3) workshop. Conceived…
Continue ReadingOn behalf of our patient community, CDF has either directly invested or fought to secure investments in diagnostics, research, and treatment for celiac disease. We have always known that this was a serious disease with broad and often devastating impacts if left undiagnosed and/or untreated. Our 25 years of hard work continues to yield returns. This is from a NY Times article published on April 29, 2015, "Pharmaceutical companies are racing to develop the first drugs for celiac disease, which researchers say is much more common than previously thought."
Continue ReadingHere at the Celiac Disease Foundation, we deeply value hearing stories from our patient community. Elevating the lived experience of people navigating celiac disease and recognizing the good work of our patient advocates are important ways to build community among our patients, caregivers, and supporters worldwide. Your stories are also...